These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26418356)

  • 1. The European antibody network's practical guide to finding and validating suitable antibodies for research.
    Roncador G; Engel P; Maestre L; Anderson AP; Cordell JL; Cragg MS; Šerbec VČ; Jones M; Lisnic VJ; Kremer L; Li D; Koch-Nolte F; Pascual N; Rodríguez-Barbosa JI; Torensma R; Turley H; Pulford K; Banham AH
    MAbs; 2016; 8(1):27-36. PubMed ID: 26418356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A dataset describing a suite of novel antibody reagents for the RAS signaling network.
    Schoenherr RM; Huang D; Voytovich UJ; Ivey RG; Kennedy JJ; Saul RG; Colantonio S; Roberts RR; Knotts JG; Kaczmarczyk JA; Perry C; Hewitt SM; Bocik W; Whiteley GR; Hiltke T; Boja ES; Rodriguez H; Whiteaker JR; Paulovich AG
    Sci Data; 2019 Aug; 6(1):160. PubMed ID: 31467290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CiteAb: a searchable antibody database that ranks antibodies by the number of times they have been cited.
    Helsby MA; Leader PM; Fenn JR; Gulsen T; Bryant C; Doughton G; Sharpe B; Whitley P; Caunt CJ; James K; Pope AD; Kelly DH; Chalmers AD
    BMC Cell Biol; 2014 Feb; 15():6. PubMed ID: 24528853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody validation: a view from the mountains.
    Taussig MJ; Fonseca C; Trimmer JS
    N Biotechnol; 2018 Oct; 45():1-8. PubMed ID: 30086383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody Validation Strategy for Nuclear Receptors.
    Katona B; Ibrahim A; Sundberg M; Williams C
    Methods Mol Biol; 2019; 1966():79-99. PubMed ID: 31041740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validating Antibody Specificities for Immunohistochemistry by Protein Blotting Methods.
    Kurien BT; Scofield RH
    Methods Mol Biol; 2017; 1554():61-73. PubMed ID: 28185183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Antibody Society's antibody validation webinar series.
    Voskuil JLA; Bandrowski A; Begley CG; Bradbury ARM; Chalmers AD; Gomes AV; Hardcastle T; Lund-Johansen F; Plückthun A; Roncador G; Solache A; Taussig MJ; Trimmer JS; Williams C; Goodman SL
    MAbs; 2020; 12(1):1794421. PubMed ID: 32748696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of D-dimer specific monoclonal antibodies for use in latex agglutination test.
    Török-Nagy B; Antal J; Dénes B
    PLoS One; 2019; 14(2):e0212104. PubMed ID: 30763351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of the decision-making process for the selection of therapeutics to undergo clinical testing for spinal cord injury in the North American Clinical Trials Network.
    Guest J; Harrop JS; Aarabi B; Grossman RG; Fawcett JW; Fehlings MG; Tator CH
    J Neurosurg Spine; 2012 Sep; 17(1 Suppl):94-101. PubMed ID: 22985376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oregovomab: anti-CA-125 monoclonal antibody B43.13--AltaRex, B43.13, MAb B43.13, monoclonal antibody B43.13.
    Drugs R D; 2006; 7(6):379-83. PubMed ID: 17073521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A call to adopt a "fit for purpose" approach to antibody validation for flow cytometry analyses of stem cell models and beyond.
    Waas M; Gundry RL
    Am J Physiol Heart Circ Physiol; 2019 Nov; 317(5):H954-H957. PubMed ID: 31559827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European collaborative study of luteinizing hormone assay: 1. Epitope specificity of luteinizing hormone monoclonal antibodies and surface mapping of pituitary and urinary luteinizing hormone.
    Costagliola S; Niccoli P; Florentino M; Carayon P
    J Endocrinol Invest; 1994 Jun; 17(6):397-406. PubMed ID: 7523479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and Characterization of Siglec-F-Specific Monoclonal Antibodies.
    Shahmohammadi-Farid S; Ghods R; Jeddi-Tehrani M; Bayat AA; Mojtabavi N; Razavi A; Zarnani AH
    Iran J Allergy Asthma Immunol; 2017 Dec; 16(6):460-470. PubMed ID: 29338152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining antigen specificity of a monoclonal antibody using genome-scale CRISPR-Cas9 knockout library.
    Zotova A; Zotov I; Filatov A; Mazurov D
    J Immunol Methods; 2016 Dec; 439():8-14. PubMed ID: 27664857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward biosimilar monoclonal antibodies.
    Schneider CK; Kalinke U
    Nat Biotechnol; 2008 Sep; 26(9):985-90. PubMed ID: 18779806
    [No Abstract]   [Full Text] [Related]  

  • 17. Directed selection of recombinant human monoclonal antibodies to herpes simplex virus glycoproteins from phage display libraries.
    Sanna PP; Williamson RA; De Logu A; Bloom FE; Burton DR
    Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6439-43. PubMed ID: 7604009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic kits in parasitology: which controls?].
    Rossi P
    Parassitologia; 2004 Jun; 46(1-2):145-9. PubMed ID: 15305705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Although it's painful: The importance of stringent antibody validation.
    Meliopoulos VA; Schultz-Cherry S
    PLoS Pathog; 2018 Jan; 14(1):e1006701. PubMed ID: 29300781
    [No Abstract]   [Full Text] [Related]  

  • 20. Selecting and screening recombinant antibody libraries.
    Hoogenboom HR
    Nat Biotechnol; 2005 Sep; 23(9):1105-16. PubMed ID: 16151404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.